Intelligence Profile
Clinical Applications
The clinical evidence for follistatin 344 is extremely limited, consisting primarily of observational studies, case reports, and preclinical research rather than controlled clinical trials. No completed clinical trials were identified in the available evidence.
Investigated Applications
Musculoskeletal and Athletic Performance
Limited evidence suggests follistatin 344 has been investigated for potential applications in muscle-related conditions and athletic performance enhancement. A 2026 review examined the safety and efficacy of various peptide therapies for musculoskeletal injuries and athletic performance, including follistatin 344, though specific clinical outcomes are not detailed in the available evidence.
Rheumatoid Arthritis (Biomarker Studies)
Observational research from 2025 identified a relationship between elevated serum follistatin levels and impaired physical function in patients with rheumatoid arthritis. However, this represents correlational research rather than therapeutic intervention studies, and the clinical significance remains unclear.
Safety Concerns
The available clinical evidence primarily highlights safety concerns rather than therapeutic benefits:
Ocular Complications
A 2020 retrospective case series documented central serous chorioretinopathy (a retinal condition causing vision problems) associated with high-dose follistatin 344 use. This represents the most substantive clinical safety data available.
Unregulated Use
Multiple reports from 2019-2020 documented the detection of follistatin 344 in black market preparations, raising concerns about unregulated use and product quality in non-clinical settings.
Evidence Limitations
The clinical evidence base for follistatin 344 is notably thin. Most available research consists of preclinical studies (such as transgenic pig models showing increased skeletal muscle mass) or basic pharmacological characterization rather than human clinical trials. The lack of controlled clinical trials means that efficacy, optimal dosing, and comprehensive safety profiles have not been established through rigorous clinical research.
Medical Disclaimer: This information is for educational purposes only and should not be considered medical advice. Any use of follistatin 344 should only be considered under appropriate medical supervision and regulatory oversight.